RheaVita Closes EUR 2.5 million Series A Financing Co-Led by Novalis Biotech Acceleration and PMV
Proceeds will be used to build first GMP compliant biopharmaceutical continuous, controlled, freeze-drying production line and accelerate commercialization of the RheaVita technology First GMP compliant
Source: finanznachrichten.de